Depot Neuroleptic Therapy: Clinical Considerations

No abstract is available for this paper.

• Publication year

  1995

• Venue

  The Canadian Journal of Psychiatry

• Publication date

  1995-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/070674379504003S02
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats.

  2009cited by this paper
• Treatment of schizophrenia.

  1995cited by this paper
• Clinical handbook of psychotropic drugs, fourth edition. By K. Z. Butler. Hogrefe and Huber. $29.50. ISBN 0‐88937‐115‐6. Psychopharmacology and electroconvulsive therapy. By L. B. Guttmacher. American Psychiatric Press. Pp. 227 + xiii. €18.95. ISBN 0‐88048‐340‐7

  1994cited by this paper
• Community care of patients receiving antipsychotic medication by depot injection.

  1993cited by this paper
• Stabilization and depot neuroleptic dosages.

  1993cited by this paper
• Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

  1993cited by this paper
• A pharmacoeconomic evaluation of clozapine in one patient.

  1993cited by this paper
• Ambulatory blood pressure measurement.

  1993cited by this paper
• Dosaging Patterns in Schizophrenia with Depot, Oral and Combined Neuroleptic Therapy

  1993cited by this paper
• Depot neuroleptic therapy: an underutilized treatment option.

  1992influential reference
• High incidence of haloperidol decanoate injection site reactions.

  1992cited by this paper
• Pharmacological Alleviation of Combined Cholinergic/Noradrenergic Lesion‐Induced Memory Deficits in Rats

  1991cited by this paper
• Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double‐blind multicentre study

  1991cited by this paper
• Outcome of involuntary medication in a state hospital system.

  1991cited by this paper
• Neuroleptic plasma levels.

  1991cited by this paper
• Depot antipsychotic drugs and prevention of psychotic relapse.

  1991influential reference
• From noncompliance to collaboration in the treatment of schizophrenia.

  1990cited by this paper
• Co-injection of zuclopenthixol acetate and zuclopenthixol decanoate

  1990cited by this paper
• Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.

  1990cited by this paper
• A two-year clinical and economic follow-up of patients on clozapine.

  1990cited by this paper
• Drug Prescribing for Schizophrenic Out-patients on Depot Injections

  1990cited by this paper
• Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.

  1990cited by this paper
• The neuroleptics: a historical survey

  1990cited by this paper
• Safety of Long-Term Neuroleptanxiolysis with Fluspirilene 1.5 mg per Week

  1990cited by this paper
• Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.

  1990cited by this paper
• [Results of a survey on the use of delayed-action neuroleptics in psychiatry].

  1990cited by this paper
• Self-injection of neuroleptics.

  1990cited by this paper
• Depot neuroleptics.

  1989cited by this paper
• Clinical pharmacokinetics : concepts and applications

  1989cited by this paper
• Issues in the use of depot antipsychotics.

  1989cited by this paper
• Persistence of fluphenazine in plasma after decanoate withdrawal.

  1988cited by this paper
• Changing from oral to depot fluphenazine.

  1988cited by this paper
• Depot neuroleptics for acutely psychotic patients.

  1987cited by this paper
• Injection site leakage of depot neuroleptics: intramuscular versus subcutaneous injection.

  1987cited by this paper
• Double-Blind Comparison of Half-Dose and Standard-Dose Flupenthixol Decanoate in the Maintenance Treatment of Stabilised Out-Patients with Schizophrenia

  1987cited by this paper
• Depot neuroleptics: side effects and safety.

  1986cited by this paper
• Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate.

  1986cited by this paper
• Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.

  1986cited by this paper
• Integrating treatments in schizophrenia.

  1986cited by this paper
• A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.

  1986cited by this paper
• An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.

  1986cited by this paper
• The natural course of schizophrenia and effective maintenance drug treatment.

  1986cited by this paper
• Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.

  1986cited by this paper
• Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients.

  1985cited by this paper
• Clinical Pharmacokinetics of the Depot Antipsychotics

  1985influential reference
• Commentary: The Strategy and Value of Neuroleptic Drug Monitoring

  1985cited by this paper
• III. Relapse Postponement or Relapse Prevention? The Implications for Long-term Outcome

  1985cited by this paper
• I. Course of Illness, Stability of Diagnosis, and the Role of a Special Maintenance Clinic

  1985cited by this paper
• High-dose versus low-dose strategies in the treatment of schizophrenia.

  1985cited by this paper
• Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment

  1985cited by this paper
• Enhancing medication use in schizophrenic patients.

  1984cited by this paper
• Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.

  1984cited by this paper
• A brief history of depot neuroleptics.

  1984cited by this paper
• Fluspirilene neuroleptic depot injections and indurations.

  1984cited by this paper
• A brief history of depot neuroleptics.

  1984cited by this paper
• Costs and benefits of two doses of fluphenazine.

  1984cited by this paper
• The use of depot neuroleptics: clinical experience in the United States.

  1984cited by this paper
• Low-dose neuroleptic treatment of outpatient schizophrenics: preliminary results for relapse rates

  1984cited by this paper
• Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.

  1984cited by this paper
• "Compendium of pharmaceuticals and specialties".

  1983cited by this paper
• Double-blind comparison between two forms of haloperidol: an oral preparation and a new depot decanoate in the maintenance of schizophrenic inpatients

  1983cited by this paper
• Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type.

  1983cited by this paper
• The subtle art of really good injections.

  1982cited by this paper
• Technique for Injecting Long-Acting Neuroleptics

  1982cited by this paper
• Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients

  1982cited by this paper
• Pharmacokinetics of haloperidol decanoate. A 2-year follow-up.

  1982cited by this paper
• A depot neuroleptic withdrawal study

  1981cited by this paper
• Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics.

  1981cited by this paper
• Theoretical and practical importance of plasma levels of haloperidol (radioimmunoassay). Correlations with clinical and CEEG data

  1981cited by this paper
• Intramuscular haloperidol decanoate for neuroleptic maintenance therapy Efficacy, dosage schedule and plasma levels AN OPEN MULTICENTER STUDY

  1980cited by this paper
• Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics.

  1978cited by this paper
• A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

  1978cited by this paper
• Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.

  1976cited by this paper
• Basic principles of rapid neuroleptization.

  1976cited by this paper
• The long-acting phenothiazines.

  1975cited by this paper
• Clinical pharmacy and therapeutics

  1975cited by this paper
• The depot fluphenazines: a reappraisal after 10 years' clinical experience.

  1975cited by this paper
• Why do schizophrenic patients refuse to take their drugs

  1974cited by this paper
• ARE ANTIPSYCHOTIC DRUGS INTERCHANGEABLE?

  1974cited by this paper
• Drug defaulting by patients on long-acting phenothiazines

  1973cited by this paper

• Long-acting injectable antipsychotics: what, when, and how

  2021cites this paper
• Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs

  2020cites this paper
• Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics

  2018cites this paper
• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal

  2014cites this paper
• Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade

  2012cites this paper
• Why aren't depot antipsychotics prescribed more often and what can be done about it?

  2005cites this paper
• Evidence for use of depot neuroleptic medication

  2004cites this paper
• Compliance and convenience: do physicians and patients see depot medication differently?

  2004cites this paper
• Sustained drug delivery optimizes long-term treatment of patients with schizophrenia

  2004cites this paper
• Is rehospitalization a measure of the efficacy of neuroleptics in the treatment of schizophrenia?

  1998cites this paper